ENANTA PHARMACEUTICALS INC (ENTA) (CIK 0001177648) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001193125-26-055328
- Form
- CORRESP
- Filer
- ENANTA PHARMACEUTICALS INC (ENTA) (CIK 0001177648)
- CIK
- 0001177648
- Ticker
- ENTA
- Filed
- 2026-02-17
- SIC industry
- 2834
- HQ
- Watertown, MA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1177648/000119312526055328/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗
Other comment-letter activity for this filer